Patents Assigned to Laboratories Almirall, S.A.
  • Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
    Patent number: 8420669
    Abstract: The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the BETA2 adrenergic receptor.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: April 16, 2013
    Assignee: Laboratories Almirall, S.A.
    Inventors: Carlos Puig Duran, Maria Isabel Crespo Crespo, Julio Cesar Castro Palomino Laria, Silvia Gual Roig, Eloisa Navarro Romero
  • Quinuclidine derivatives and medicinal compositions containing the same
    Patent number: 7358260
    Abstract: The invention provides 1-phenethyl-3 (R)-(9[H]-xanthene-9-carbonyloxy)-1 -azoniabicyclo[2.2.2]octane in salt form, pharmaceutical compositions comprising it, and methods of using it for treatment of respiratory disorders.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: April 15, 2008
    Assignee: Laboratories Almirall, S.A.
    Inventors: María Dolors Fernandez Forner, María Prat Quiñones, María Antonia Buil Albero